Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update

Go back to Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
(NASDAQ: ACHV) Delayed: 5.10 +0.25 (5.15%)
Previous Close $4.85    52 Week High
Open $4.94    52 Week Low
Day High $5.43    P/E N/A 
Day Low $4.94    EPS
Volume 2,899,433